Selegiline and depressed level of consciousness Patient Reports February 11, 2012

Selegiline Side Effects Report #5897179-1
Selegiline side effect was reported by a Health Professional from UNITED STATES on July 25, 2008. Male patient, 62 years of age, weighting 191.4 lb, was diagnosed with parkinson's disease  and was treated with Selegiline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood pressure systolic increased, blood sodium decreased, cerebral amyloid angiopathy, cerebral haemorrhage, confusional state, convulsion, depressed level of consciousness, fluid overload. Selegiline dosage: 5 MG;BID;PO. During the same period patient was treated with ASPIRIN, ATENOLOL, AMANTADINE, SIMVASTATIN, UBIDECARENONE, CENTRUM SILVER, DOCUSATE. Patient was hospitalized. Patient recovered.